Ivan A. Chabin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ivan A. Chabin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Nataliya Sergeevna Smetanina
National Scientific and Practical Center for Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Moscow, Russia
5 shared publications - Mikhail Aleksandrovich Panteleev
Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, Russia
4 shared publications - Nadezhda A. Podoplelova
Center for Theoretical Problems of Physicochemical Pharmakology, 119991 Moscow, Russia
3 shared publications - Anna S. Suvorova
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Healthcare, Samora Machel Street, 1, GSP-7, Moscow 117198, Russia
2 shared publications - Dmitry S. Prudinnik
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Healthcare, Samora Machel Street, 1, GSP-7, Moscow 117198, Russia
2 shared publications - Elena Ivanovna Sinauridze
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Healthcare, Samora Machel Street, 1, GSP-7, Moscow 117198, Russia
2 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7654
Differential Diagnosis of Anemia Using the Erythrocyte Filterability Method
Hereditary hemolytic anemias (HHAs) have very similar clinical manifestations, complicating differential diagnosis and determining treatment strategies, such as splenectomy. To differentiate between hereditary spherocytosis (HS), pyruvate kinase deficiency (PKD), and hereditary stomatocytosis (HSt), we proposed measuring erythrocyte filterability using membrane filters with a pore diameter of 3 or 3.5 μm. Our modified method provides improved reproducibility, reducing the scattering in results caused by differences in the filters used. Erythrocytes’ filterability differs significantly between patients with HS, HSt, and PKD (medians and 95% confidence intervals were 0.025 [0.004; 0.100] (n = 86); 0.645 [0.520; 0.730] (n = 10), and 0.760 [0.700; 0.782] (n = 26), respectively). The specificity of the filterability test for the HS diagnosis was 99.1%, comparable with the best available tests, while its sensitivity (85.4%) was slightly lower than that of some alternative methods. Only the filterability test was able to identify a second subgroup of HS patients (14.0%) with higher filterability (close to normal), but the diagnosis of HS in these patients could be confirmed by reduced filterability on a 3-μm filter. This subgroup requires further detailed study. The proposed method for measuring filterability is promising for diagnosing HS. It has high sensitivity and specificity and can be performed quickly without expensive equipment.
- 26 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7654
Open AccessDifferential Diagnosis of Anemia Using the Erythrocyte Filterability Method
Hereditary hemolytic anemias (HHAs) have very similar clinical manifestations, complicating differential diagnosis and determining treatment strategies, such as splenectomy. To differentiate between hereditary spherocytosis (HS), pyruvate kinase deficiency (PKD), and hereditary stomatocytosis (HSt), we proposed measuring erythrocyte filterability using membrane filters with a pore diameter of 3 or 3.5 μm. Our modified method provides improved reproducibility, reducing the scattering in results caused by differences in the filters used. Erythrocytes’ filterability differs significantly between patients with HS, HSt, and PKD (medians and 95% confidence intervals were 0.025 [0.004; 0.100] (n = 86); 0.645 [0.520; 0.730] (n = 10), and 0.760 [0.700; 0.782] (n = 26), respectively). The specificity of the filterability test for the HS diagnosis was 99.1%, comparable with the best available tests, while its sensitivity (85.4%) was slightly lower than that of some alternative methods. Only the filterability test was able to identify a second subgroup of HS patients (14.0%) with higher filterability (close to normal), but the diagnosis of HS in these patients could be confirmed by reduced filterability on a 3-μm filter. This subgroup requires further detailed study. The proposed method for measuring filterability is promising for diagnosing HS. It has high sensitivity and specificity and can be performed quickly without expensive equipment.
- Open Access
- 5 August 2026
- Published by MDPI AG in Preprints.org
Differential Diagnosis of Anemia Using the Erythrocyte Filterability Method
Hereditary hemolytic anemias (HHAs) have quite similar clinical manifestations, complicating differential diagnosis and determining treatment, such as splenectomy. For the differential diagnosis of hereditary spherocytosis (HS), pyruvate kinase deficiency (PKD), and hereditary stomatocytosis (HSt), we proposed to measure erythrocyte filterability through membrane filters with a pore diameter of 3 or 3.5 μm. Our modified method provides improved reproducibility reducing the variation in results caused by differences in the filters used. The filterability of erythrocytes significantly differs in patients with HS, HSt and PKD (medians and 1.5 IQR were: 0.045 [0; 0.51] (n=88); 0.685 [0.46; 0.79] (n=12) and 0.75 [0.55; 0.86] (n=28) rel. un., respectively). The specificity of the filterability test for HS diagnosis was 100%, comparable to the best available tests, while its sensitivity (85.2%) was somewhat lower than that of some alternative methods. Only the filterability test could identify a second subgroup in HS patients (14.8%) with higher filterability (close to normal), but their HS diagnosis was confirmed by the decreased filterability by 3-µm pore filter. This subgroup requires further detailed study. The proposed filterability measurement method is promising for diagnosing HS. It has high sensitivity and specificity and can be performed quickly without expensive equipment.
- 5 August 2026
- Published by MDPI AG in Preprints.org
Open AccessDifferential Diagnosis of Anemia Using the Erythrocyte Filterability Method
Hereditary hemolytic anemias (HHAs) have quite similar clinical manifestations, complicating differential diagnosis and determining treatment, such as splenectomy. For the differential diagnosis of hereditary spherocytosis (HS), pyruvate kinase deficiency (PKD), and hereditary stomatocytosis (HSt), we proposed to measure erythrocyte filterability through membrane filters with a pore diameter of 3 or 3.5 μm. Our modified method provides improved reproducibility reducing the variation in results caused by differences in the filters used. The filterability of erythrocytes significantly differs in patients with HS, HSt and PKD (medians and 1.5 IQR were: 0.045 [0; 0.51] (n=88); 0.685 [0.46; 0.79] (n=12) and 0.75 [0.55; 0.86] (n=28) rel. un., respectively). The specificity of the filterability test for HS diagnosis was 100%, comparable to the best available tests, while its sensitivity (85.2%) was somewhat lower than that of some alternative methods. Only the filterability test could identify a second subgroup in HS patients (14.8%) with higher filterability (close to normal), but their HS diagnosis was confirmed by the decreased filterability by 3-µm pore filter. This subgroup requires further detailed study. The proposed filterability measurement method is promising for diagnosing HS. It has high sensitivity and specificity and can be performed quickly without expensive equipment.
- Open Access
- 14 April 2026
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 25 (1) , 74-81
Essential thrombocythemia in childhood: features of platelet structure and function
Introduction. Essential thrombocythemia (ET) is an orphan myeloproliferative disease with excessive platelet production associated with an increased risk of thrombosis and bleeding. Currently, there is a limited number of studies on the state of platelet hemostasis in children with ET. Aim of this single-center prospective study was to characterize the morphological and functional properties of platelets in pediatric patients with ET. Materials and methods. The study included 30 patients (10 boys and 20 girls) aged 3–17 years with an established diagnosis of ET. The control group consisted of 45 healthy volunteers (22 boys and 23 girls) aged 4–18 years. Flow cytometry with strong and weak activation, aggregometry, and immunofluorescence microscopy of blood smears were used to analyze platelet function. Results. It was shown that platelets of patients with ET are characterized by a reduced size, while the number of platelet alpha and dense granules did not differ from the control group. Platelets of patients with ET showed moderate hyporeactivity in response to strong stimulation (by activation of glycoprotein IIbIIIa and secretion of dense granules). Platelet aggregation with collagen and adenosine diphosphate was also reduced in patients with ET, but these data did not correlate with the degree of platelet activation in flow cytometry. Conclusion. Thus, characteristic morphological and functional changes in platelets were revealed in children with ET compared with the control group.
- 14 April 2026
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 25 (1) , 74-81
Open AccessEssential thrombocythemia in childhood: features of platelet structure and function
Introduction. Essential thrombocythemia (ET) is an orphan myeloproliferative disease with excessive platelet production associated with an increased risk of thrombosis and bleeding. Currently, there is a limited number of studies on the state of platelet hemostasis in children with ET. Aim of this single-center prospective study was to characterize the morphological and functional properties of platelets in pediatric patients with ET. Materials and methods. The study included 30 patients (10 boys and 20 girls) aged 3–17 years with an established diagnosis of ET. The control group consisted of 45 healthy volunteers (22 boys and 23 girls) aged 4–18 years. Flow cytometry with strong and weak activation, aggregometry, and immunofluorescence microscopy of blood smears were used to analyze platelet function. Results. It was shown that platelets of patients with ET are characterized by a reduced size, while the number of platelet alpha and dense granules did not differ from the control group. Platelets of patients with ET showed moderate hyporeactivity in response to strong stimulation (by activation of glycoprotein IIbIIIa and secretion of dense granules). Platelet aggregation with collagen and adenosine diphosphate was also reduced in patients with ET, but these data did not correlate with the degree of platelet activation in flow cytometry. Conclusion. Thus, characteristic morphological and functional changes in platelets were revealed in children with ET compared with the control group.
- Open Access
- 30 June 2025
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (2) , 104-110
Detection of phosphatidylserine-expressing red blood cells in whole blood
There are various mechanisms of red blood cell (RBC) clearance from the circulation, including eryptosis and hemolysis. The spleen plays a major role in eliminating RBCs from the blood flow thanks to their ability to pass through narrow spaces. Still, some questions such as the role of phosphatidylserine-binding proteins in this process remain unanswered. Thus, RBC elimination mechanisms are still not very well explored. Here, we report on a flow cytometry protocol using phosphatidylserine markers for the detection of whole blood erythrocytes that can be classified as pre-elimination RBCs. We also provide the results of healthy donors' blood testing suggesting that reliable detection of eryptosis in whole blood is indeed possible. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia.
- 30 June 2025
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (2) , 104-110
Open AccessDetection of phosphatidylserine-expressing red blood cells in whole blood
There are various mechanisms of red blood cell (RBC) clearance from the circulation, including eryptosis and hemolysis. The spleen plays a major role in eliminating RBCs from the blood flow thanks to their ability to pass through narrow spaces. Still, some questions such as the role of phosphatidylserine-binding proteins in this process remain unanswered. Thus, RBC elimination mechanisms are still not very well explored. Here, we report on a flow cytometry protocol using phosphatidylserine markers for the detection of whole blood erythrocytes that can be classified as pre-elimination RBCs. We also provide the results of healthy donors' blood testing suggesting that reliable detection of eryptosis in whole blood is indeed possible. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia.
- Open Access
- 30 June 2025
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (2) , 80-85
Cytofluorometry analysis of red blood cell suspension properties: results of a pilot study
A wide use of blood products inevitably leads to an increase in the number of complications associated with it. These complications include thromboembolic events that are considered to be rare and difficult-to-manage. Currently, the mechanisms and possible laboratory predictors of such complications are unclear. This paper presents our experience of using flow cytometry to assess the parameters of phosphatidylserine expression (detected by Annexin V binding) and describes impairments in the deformability of red blood cells (detected using forward and side scatter data) which determine the procoagulant properties of cells. According to our findings, the use of Annexin V for the assessment of gradual cell death in the samples of red blood cell (RBC) suspension is controversial. At the same time, our results show a higher sensitivity of the assessment of the accumulation of RBCs with an altered shape for the detection of programmed cell death - eryptosis. The obtained results can be used to improve the detection of dead RBCs during the routine storage of RBC suspension. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation.
- 30 June 2025
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (2) , 80-85
Open AccessCytofluorometry analysis of red blood cell suspension properties: results of a pilot study
A wide use of blood products inevitably leads to an increase in the number of complications associated with it. These complications include thromboembolic events that are considered to be rare and difficult-to-manage. Currently, the mechanisms and possible laboratory predictors of such complications are unclear. This paper presents our experience of using flow cytometry to assess the parameters of phosphatidylserine expression (detected by Annexin V binding) and describes impairments in the deformability of red blood cells (detected using forward and side scatter data) which determine the procoagulant properties of cells. According to our findings, the use of Annexin V for the assessment of gradual cell death in the samples of red blood cell (RBC) suspension is controversial. At the same time, our results show a higher sensitivity of the assessment of the accumulation of RBCs with an altered shape for the detection of programmed cell death - eryptosis. The obtained results can be used to improve the detection of dead RBCs during the routine storage of RBC suspension. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation.
- Open Access
- 13 December 2024
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 23 (4) , 54-57
Analysis of platelet inhibition function by measuring phosphorylation of the intracellular cytoskeleton protein VASP in whole blood over time
The state of platelets may depend on the time since blood draw, primarily because of the presence of short-lived inhibitors of platelet activation in circulation. In this work, we analyzed the phosphorylation of vasodilator-stimulated phosphoprotein (VASP), which correlates with platelet inhibition, over time using flow cytometry. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. We investigated VASP phosphorylation in platelets in whole blood immediately after the blood was collected and 60 minutes later. As a positive control, we used platelet function inhibition by prostaglandin E1. As a result, it was found that the level of VASP phosphorylation in platelets in whole blood did not differ significantly in samples taken immediately after the blood draw and 60 minutes later, however it was markedly increased with platelet inhibition by prostaglandin E1. Our results suggest that the state of platelets does not change significantly within 60 minutes after the blood draw.
- 13 December 2024
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 23 (4) , 54-57
Open AccessAnalysis of platelet inhibition function by measuring phosphorylation of the intracellular cytoskeleton protein VASP in whole blood over time
The state of platelets may depend on the time since blood draw, primarily because of the presence of short-lived inhibitors of platelet activation in circulation. In this work, we analyzed the phosphorylation of vasodilator-stimulated phosphoprotein (VASP), which correlates with platelet inhibition, over time using flow cytometry. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. We investigated VASP phosphorylation in platelets in whole blood immediately after the blood was collected and 60 minutes later. As a positive control, we used platelet function inhibition by prostaglandin E1. As a result, it was found that the level of VASP phosphorylation in platelets in whole blood did not differ significantly in samples taken immediately after the blood draw and 60 minutes later, however it was markedly increased with platelet inhibition by prostaglandin E1. Our results suggest that the state of platelets does not change significantly within 60 minutes after the blood draw.